T1	Intervention 609 672	Patients were titrated to tapentadol PR 300 mg/day over 3 weeks
T2	Intervention 761 891	randomized to tapentadol PR (500 mg/day) or tapentadol PR (300 mg/day)/pregabalin (300 mg/day) during an 8-week comparative period
